Najlepsi lekarze wykonujący mapowanie znamion i cyfrową dermoskopię do oceny znamion w Stambule – TOP 2 lekarzy

Assoc. Prof. Dr. Asli Tatliparmak is a dermatologist at Memorial Bahçelievler Hospital (2025–present). She previously served as Associate Professor at Medicana Ataköy (2023–2024) and at Şişli Kolan International (2021–2023). She was Head of Dermatology at İstinye University Liv Hospital (2018–2021). She earned her M.D. from Ege University in 2006. She completed her Dermatology and Venereology residency there in 2012. She earlier held specialist posts at Artvin State and Medical Park Fatih.

Achievements include the Best Oral Presentation Award at the IVth Aegean Dermatology Days (2008). She is editor of two international medical books. She has written three international and five national book chapters. Her record includes 19 international and 31 national publications. She has given many presentations and is an invited speaker. She is a member of EADV and EHSF. She also belongs to the Turkish Dermatology Association (Nail Diseases and Autoinflammatory Working Groups), the Dermatooncology Association, the İstanbul Association of Dermatology and Venereology, and the Turkish Medical Association.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.